Just received glut from CN. Ill be doing about 600mgs (conventional) dose weekly IM. Don't know how much bacc Ill be using yet. Heres is the translation of the leaflet and box by chatgpt: (might add to the convo yall were having)
Sure — these documents are instructions for
注射用还原型谷胱甘肽 (Zhùshèyòng huányuánxíng gǔguāngāitài), which translates to
“Reduced Glutathione for Injection.”
Below is a faithful English translation of both sides of the leaflet you photographed:
Reduced Glutathione for Injection
[Generic Name]
Reduced Glutathione for Injection (注射用还原型谷胱甘肽)
[Ingredients]
The main ingredient is
reduced glutathione.
Chemical name:
L-γ-glutamyl-L-cysteinyl-glycine
Molecular formula:
C10H17N3O6S
Molecular weight:
307.32
[Description]
This product is a white or almost white loose powder or mass.
[Pharmacological Action]
Reduced glutathione (GSH) is a tripeptide compound containing a sulfhydryl group (-SH). It is an important antioxidant that exists widely in living organisms.
It participates in various important biochemical reactions inside the body, including detoxification, maintaining redox balance, and protecting cell membranes and proteins from oxidative damage.
In the human body, it plays major roles in:
- Maintaining cell integrity
- Detoxifying harmful substances
- Supporting liver function
- Regulating immune response
- Assisting amino acid transport and metabolism
It can prevent or mitigate liver damage caused by drugs, poisons, or radiation, and can also protect hemoglobin from oxidation.
[Pharmacokinetics]
After intravenous injection, glutathione is distributed in body tissues and rapidly metabolized.
It mainly acts in the liver and is eventually excreted in the form of oxidized glutathione (GSSG) or other metabolites through urine.
[Indications]
Used for:
- Adjuvant treatment of chronic hepatitis, liver cirrhosis, fatty liver, and toxic liver injury.
- As an antioxidant for various oxidative stress–related conditions.
- To prevent and treat drug or chemical poisoning (e.g., carbon tetrachloride, alcohol, heavy metals, or chemotherapy-related liver injury).
- To reduce melanin formation and for skin-whitening purposes in some cases (cosmetic indication not officially therapeutic).
[Dosage and Administration]
- Adult dosage: 0.6–1.2 g once daily.
- Dissolve in 5–500 mL of 5% glucose solution or normal saline for intravenous drip, infused slowly over 15–30 minutes.
- Use the freshly prepared solution immediately.
Notes:
- Do not mix with vitamin B12, vitamin K3, riboflavin, ascorbic acid (vitamin C), or oxidative/reducing agents, as they may cause decomposition.
- Avoid contact with metal ions such as copper, iron, or other heavy metals.
- The solution should be colorless and transparent; if turbid or discolored, do not use.
[Adverse Reactions]
Generally well tolerated.
Occasionally:
- Fever, rash, local irritation at the injection site.
- Nausea, vomiting, or mild allergic reactions.
Discontinue use if severe reactions occur.
[Contraindications]
- Hypersensitivity to glutathione or any excipients.
- Pregnant or lactating women should use with caution under medical supervision.
[Precautions]
- Use strictly according to the doctor’s advice.
- Avoid prolonged exposure to light or high temperature.
- The product is for intravenous use only and must be prepared freshly each time.
- Pediatric and elderly use should follow medical guidance.
- Avoid mixing with incompatible drugs in the same solution.
[Drug Interactions]
- May interact with chemotherapy agents, potentially reducing their efficacy if used simultaneously (especially cisplatin or alkylating agents).
- Use separately as directed by a physician.
[Storage]
Store in a
cool, dry place, protected from light.
Temperature should not exceed
20 °C (68 °F).
[Packaging]
- 0.6 g per vial × 1 vial per box
- 1.2 g per vial × 1 vial per box
[Shelf Life]
24 months
[Manufacturer]
Hubei Renfu Pharmaceutical Co., Ltd.
Address: No. 304, Donghu New Technology Development Zone, Wuhan, Hubei Province, China
Postal Code: 430074
Tel: 027-87431869
Website:
http://www.hbrfpharm.com/hbrfxy/
Production license:
H20051213
Approval number:
国药准字 H20051213
Standards: Chinese Pharmacopoeia 2015 edition, part II